The Associate Director, Early Commercial Strategy and Insights will be responsible for helping to develop and execute the commercial insights strategy for Dianthus’ programs, DNTH212 and clauseprubart, across multiple autoimmune and rare disease indications. This includes generating actionable market insights, competitive intelligence, forecasting, and strategic recommendations to support development and commercialization planning for DNTH212 in SLE, Sjögrens syndrome, and Dermatomyositis, as well as claseprubart in Myasthenia Gravis (MG), Chronic Inflammatory, Demyelinating Polyneuropathy (CIDP), and Mutifocal Motor Neuropathy (MMN).
Reporting to the Senior Director, you will be a key member of a growing commercial organization, partnering closely with cross functional teams to shape development strategy, assess market opportunities, and support critical business decisions across both programs.
We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Experience
Discover exciting opportunities in sports technology. Join innovative companies transforming the sports industry through data, media, and cutting-edge tech.
Salary: $180000-250000
🤖 This salary estimate is calculated by AI based on the job title, location, company, and market data. Use this as a guide for salary expectations or negotiations. The actual salary may vary based on your experience, qualifications, and company policies.
Interested in building your career at Dianthus Therapeutics? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
Dianthus Therapeutics
Dianthus Therapeutics
Dianthus Therapeutics
Dianthus Therapeutics
Dianthus Therapeutics
Dianthus Therapeutics